Barış, V. Ö. Et Al. 2023. Empagliflozin attenuates doxorubicin-induced cardiotoxicity. TOXICOLOGY RESEARCH , vol.12, no.5 , 998.

Barış, V. Ö., Dinçsoy, A. B., Gedikli, E., Zırh, S., Müftüoğlu, S., & Erdem, A., (2023). Empagliflozin attenuates doxorubicin-induced cardiotoxicity. TOXICOLOGY RESEARCH , vol.12, no.5, 998.

Barış, Veysel Et Al. "Empagliflozin attenuates doxorubicin-induced cardiotoxicity," TOXICOLOGY RESEARCH , vol.12, no.5, 998, 2023

Barış, Veysel Ö. Et Al. "Empagliflozin attenuates doxorubicin-induced cardiotoxicity." TOXICOLOGY RESEARCH , vol.12, no.5, pp.998, 2023

Barış, V. Ö. Et Al. (2023) . "Empagliflozin attenuates doxorubicin-induced cardiotoxicity." TOXICOLOGY RESEARCH , vol.12, no.5, p.998.

@article{article, author={Veysel Özgür Barış Et Al. }, title={Empagliflozin attenuates doxorubicin-induced cardiotoxicity}, journal={TOXICOLOGY RESEARCH}, year=2023, pages={998} }